PubMed HealthSearch

PubMed · 44923

The role of Bacteroides melaninogenicus and other anaerobes in periodontal infections.

Abstract

Recent taxonomic and anatomical studies of dental plaque associated with periodontal health and disease have demonstrated that differences in the microbial populations in plaque may be responsible for the initiation and progression of disease. The consistent isolation of large numbers of anaerobic and capnophilic bacteria from the depths of periodontal lesions has suggested an important role for these organisms. Bacteria that have been isolated include Capnocytophaga (Bacteroides ochraceus), other species of Bacteroides, Fusobacterium, Selenomonas, spirochetes, Campylobacter, Veillonella, Actinomyces, Propionibacterium, Peptococcus, and other genera. The periodontopathic potential of oral strains of Bacteroides melaninogenicus has been explored in a number of investigations because these organisms are consistently isolated from periodontal lesions. Studies of B. melaninogenicus have included purification of a capsular substance, characterization of the lipopolysaccharide and a variety of toxic substances and lytic enzymes, and ecologic aspects of its colonization. Understanding of the nature and pathogenic mechanisms of the oral microbiota may lead to control of this pandemic infection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M G Newman. The role of Bacteroides melaninogenicus and other anaerobes in periodontal infections.. https://doi.org/10.1093/clinids%2F1.2.313

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Carbenicillin for treatment of Bacteroides fragilis infections: why not penicillin G?

Carbenicillin has been advocated for treatment of infections caused by Bacteroides fragilis and other anaerobic bacteria. Wide-scale use of the drug in this setting could result in a substantial increase in carbenicillin-resistant Pseudomonas aeruginosa, an effect that would have serious implications. Thirty-four strains of B. fragilis, one-half from bacteremic infections, were tested in vitro, and penicillin G was found to be twice as active as carbenicillin on an equal weight basis; 94% of the strains were inhibited by 32 microgram of penicillin/ml, a level easily achieved therapeutically. Penicillin killed B. fragilis organisms as rapidly as carbenicillin. In two subjects given equivalent doses (100 mg/kg intravenously) of carbenicillin and aqueous penicillin G, the bactericidal activity of serum against B. fragilis after administration of each drug was the same. Controlled clinical trials of treatment of anaerobic bacterial infections with penicillin G in high dosage, carbenicillin (or closely related ticarcillin), clindamycin, and chloramphenicol should be undertaken. Carbenicillin (and ticarcillin) for the present would seem better reserved for P. aeruginosa infections.

Bacteroides Infections